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ABSTRACT
Background: Early diagnosis and treatment of leukemia patients remains a fundamental aim in clinical 
oncology, especially in developing country. Present study highlights the basic requirements of these patients 
in Iran. Better understanding of these issues may lead to improve the healthcare standards toward leukemia 
diagnosis and treatment. 
Methods: This descriptive study included 101 specialists in hematology-oncology and pathology serving in 
oncology centers. The participants were then asked to fill out a standard questionnaire on the issues around 
diagnosis and treatment of blood malignancies.
Results: According to specialists, unfair distribution of facilities across the country, delayed diagnosis of 
disease, absence of psychological support for patients, and insufficient financial support were the main 
reasons of inappropriate diagnosis and treatment in leukemia patients.
Conclusions: Our results show that making an amendment to health policies by preparing well-equipped 
medical centers in all provinces, improving the morale of patients through consultation during the process of 
treatment, and above all, subsiding leukemia patients' financial problems will promote the health standard 
regarding the leukemia diagnosis and treatment in Iran.
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INTRODUCTION
   After cardiovascular diseases, cancers are the 
second most common cause of mortality in 
developed countries, and the third in 
underdeveloped countries. The significance of 
cancers as a major health problem has been 
revealed by the increasing incidence over the world 
by which the economic and psychological status of 
families can be affected.1 Statistically, the rate of 
cancers in Iran is increasing and it is much higher 
than standard levels.2,3 According to the Iranian 
Ministry of Health (2007), exclusively based on the 
report of Pathology Center, cancers of skin, breast, 
stomach, colorectal, liver, hematopoietic system, 
esophagus, prostate, lung, brain, and the central 
nervous system (CNS) are the most prevalent 
